Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XXII | US
-0.10
-17.24%
Healthcare
Biotechnology
30/06/2024
02/06/2026
0.48
0.58
0.58
0.48
22nd Century Group Inc. an agricultural biotechnology company focuses on tobacco harm reduction reduced nicotine tobacco and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical therapeutic and agricultural uses as well as other applications. 22nd Century Group Inc. was founded in 1998 and is headquartered in Buffalo New York.
View LessLow Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
93.9%1 month
159.5%3 months
114.6%6 months
111.1%-
-
0.38
-10.72
0.43
-0.47
0.39
-
-27.08M
15.09M
15.09M
-
-25.76
-
-1.30
-105.57
0.02
1.04
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.18
Range1M
0.54
Range3M
4.15
Rel. volume
0.52
Price X volume
216.69K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| iBio Inc | IBIO | Biotechnology | 1.76 | 16.08M | -6.88% | n/a | 20.92% |
| NeuroSense Therapeutics Ltd. Ordinary Shares | NRSN | Biotechnology | 0.8 | 15.85M | -1.57% | n/a | -2.11% |
| VistaGen Therapeutics Inc | VTGN | Biotechnology | 0.58 | 15.69M | -10.42% | n/a | 1.90% |
| Zivo Bioscience Inc | ZIVO | Biotechnology | 4.45 | 15.40M | n/a | -25.20% | |
| Adial Pharmaceuticals Inc | ADIL | Biotechnology | 2.36 | 15.12M | -3.67% | n/a | 0.00% |
| ICU | ICU | Biotechnology | 3.53 | 14.80M | -3.02% | n/a | -45.50% |
| CytoMed Therapeutics Limited Ordinary Shares | GDTC | Biotechnology | 1.14 | 13.16M | -0.10% | n/a | 3.98% |
| Kezar Life Sciences Inc | KZR | Biotechnology | 0.18 | 13.13M | 5.88% | n/a | 11.69% |
| Kala Pharmaceuticals Inc | KALA | Biotechnology | 2.39 | 13.10M | 8.64% | n/a | 268.29% |
| PLUR | PLUR | Biotechnology | 2.365 | 12.94M | -1.87% | n/a | 30845.83% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.11 | 16.22M | -2.63% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.4275 | 8.26M | -0.47% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.71 | 4.37M | 1.18% | n/a | 17.32% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0063 | 580.95K | 12.50% | n/a | -37.05% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4821 | 265.64K | -11.54% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.47 | - | Cheaper |
| Ent. to Revenue | 0.39 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.38 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 114.64 | - | Riskier |
| Debt to Equity | -10.72 | -1.23 | Cheaper |
| Debt to Assets | 0.43 | 0.25 | Expensive |
| Market Cap | 15.09M | - | Emerging |